Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients
SUVIDEM
1 other identifier
interventional
226
1 country
1
Brief Summary
Uni-centric, randomized, open-label, prospective interventional-comparative study, with a control arm (patients receiving standard preoperative information) and an experimental arm (patients receiving standard preoperative information and having access to a dematerialized educational video support).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lung-cancer
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 11, 2024
CompletedFirst Submitted
Initial submission to the registry
August 27, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 11, 2026
CompletedAugust 29, 2024
August 1, 2024
1.5 years
August 27, 2024
August 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Immediate pre-operative anxiety
self-measurement using the HAD Scale
10 days
Secondary Outcomes (5)
Perioperative anxiety (randomization (consultation), immediate postoperative and discharge)
90 days
Post-traumatic stress disorder
90 days
Quality of life evaluation
90 days
Cumulative postoperative morbidity
90 days
Intra-hospital consumption of analgesics
90 days
Study Arms (2)
experimental
EXPERIMENTALcontrol
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Patients aged 18 or over,
- Patients requiring surgical management:
- for therapeutic purposes (in the case of proven tumor histology) or for diagnostic and therapeutic purposes (in the absence of proven histology, but strong suspicion, after validation by RCP),
- \- Patients who have given their consent.
You may not qualify if:
- Patients under guardianship
- Patients with a history of thoracic surgery
- Patients on long-term analgesic medication
- Patients who do not speak French
- Patients unable to read or write
- Patients with major visual impairment
- Patients with chronic anxiety or depression at the time of admission
- Patients under guardianship
- Pregnant or breast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance publique Hopitaux de Marseille - Hopital Nord
Marseille, 13015, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2024
First Posted
August 29, 2024
Study Start
July 11, 2024
Primary Completion
January 11, 2026
Study Completion
April 11, 2026
Last Updated
August 29, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share